Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings

被引:41
|
作者
Winhusen, Theresa [1 ]
Theobald, Jeff [1 ]
Kaelber, David C. [2 ,3 ,4 ,5 ,6 ]
Lewis, Daniel [1 ]
机构
[1] Univ Cincinnati, Addict Sci Div, Dept Psychiat & Behav Neurosci, Coll Med, 3131 Harvey Ave, Cincinnati, OH 45229 USA
[2] MetroHlth Syst, Dept Informat Serv, Cleveland, OH USA
[3] Case Western Reserve Univ, Dept Internal Med, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA
[5] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[6] MetroHlth Syst, Ctr Clin Informat Res & Educ, Cleveland, OH USA
关键词
Electronic health record (EHR); hypertension; medical complications; mortality; substance use disorder (SUD); type 2 diabetes mellitus; MYOCARDIAL-INFARCTION; MORTALITY; THERAPY; EVENTS; ADULTS;
D O I
10.1111/add.14607
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background and Aims Screening for substance use disorder (SUD) in general medical settings may be particularly important in patients with comorbid health conditions exacerbated by SUD. This study evaluated whether SUD is associated with type 2 diabetes mellitus (T2DM) complications in patients with co-occurring T2DM and hypertension. Design Analysis of a limited data set obtained through IBM Watson Health Explorys, a platform integrating data from electronic health records. Matched controls were defined for each of five SUDs: tobacco use disorder (TUD), opioid use disorder (OUD), cocaine use disorder, cannabis use disorder (CUD) and alcohol use disorder (AUD) using Mahalanobis distance within propensity score calipers. Setting All patients were seen in the MetroHealth System (Cleveland, OH, USA) and had diagnosis codes for T2DM and hypertension. Participants SUD group participants had a diagnosis of abuse/dependence for the substance of interest. Controls for each SUD group had no diagnosis code related to the SUD of interest and were selected to match the SUD patients on demographics, residential zip code median income and body mass index. Total sample sizes for each SUD-control comparison ranged from 1160 for CUD to 22 128 for TUD. Measurements Outcome was diagnosis (yes/no) of four T2DM complications (cerebrovascular accident, diabetic neuropathy, diabetic renal disease, myocardial infarction) and all-cause mortality. Findings Logistic regressions revealed that SUD was significantly associated with greater risk of cerebrovascular accident [TUD odds ratio (OR) = 1.79, OUD-OR = 1.94, cocaine use disorder OR = 2.67], diabetic neuropathy [TUD-adjusted OR (aOR) = 1.47, cocaine use disorder-aOR = 1.35, AUD-aOR = 1.27], diabetic renal disease (TUD-aOR = 1.25, OUD-OR = 1.34), myocardial infarction (TUD-OR = 1.96, OUD-OR = 2.01, cocaine use disorder-OR = 2.68, CUD-OR = 2.48, AUD-OR = 1.42) and mortality (TUD-OR = 1.15, cocaine use disorder-OR = 1.61, CUD-OR = 1.49, AUD-OR = 1.35). Conclusions Among patients in Ohio USA with both type 2 diabetes mellitus (T2DM) and hypertension, those with substance use disorders appear to have greater risk for T2DM complications and all-cause mortality.
引用
收藏
页码:1462 / 1470
页数:9
相关论文
共 50 条
  • [1] Health outcomes associated with patterns of substance use disorders among patients with type 2 diabetes and hypertension: Electronic health record findings
    Khan, Md Tareq Ferdous
    Lewis, Daniel
    Kaelber, David C.
    Winhusen, T. John
    [J]. PRIMARY CARE DIABETES, 2023, 17 (01) : 43 - 47
  • [2] Increased Morbidity and Mortality in Hypertensive Patients With Substance Use Disorders: Electronic Health Record Findings
    Winhusen, Theresa
    Theobald, Jeff
    Kaelber, David C.
    Lewis, Daniel
    [J]. JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2020, 81 (04) : 471 - 478
  • [3] ILLNESS SEVERITY ASSOCIATED WITH COMORBID SUBSTANCE USE DISORDERS IN SCHIZOPHRENIA: AN ELECTRONIC HEALTH RECORD STUDY
    Patel, R.
    Chan, K. M. Y.
    Valko, M.
    Guruswamy, G.
    Ker, S.
    Batra, G.
    Kollins, S. h
    Renteria, M. E.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S465 - S465
  • [4] Integrating information on substance use disorders into electronic health record systems
    Tai, Betty
    McLellan, A. Thomas
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2012, 43 (01) : 12 - 19
  • [5] COMORBIDITIES, COMPLICATIONS, AND SURGICAL PROCEDURES IN TYPE 2 DIABETES PATIENTS: RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORD DATA
    Peyerl, F. W.
    Khangmlov, V. S.
    Ravindranath, A. J.
    Marinaro, X. F.
    Hwang, S.
    D'Souza, F. T.
    [J]. VALUE IN HEALTH, 2018, 21 : S68 - S69
  • [6] The Use of a Diabetes Electronic Medical Record Template Leads to Consistent Improvement of Screening for Complications of Type 1 Diabetes Mellitus
    Choudhary, Deepak
    Brown, Brande
    Albokhari, Daniah
    Elfadil, Sundus
    Khawar, Nayaab
    Narula, Pramod
    Agdere, Levon
    [J]. PEDIATRICS, 2018, 142
  • [7] Use of the electronic medical record to evaluate pharmacological treatment of hypertension in veterans with diabetes
    Pogach, LM
    Hawley, G
    [J]. DIABETES, 2001, 50 : A255 - A255
  • [8] Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination
    Kimberly N. Walter
    Julie A. Wagner
    Eda Cengiz
    William V. Tamborlane
    Nancy M. Petry
    [J]. Current Diabetes Reports, 2017, 17
  • [9] Use of the Electronic Medical Record to Assess Pancreas Size in Type 1 Diabetes
    Virostko, John
    Hilmes, Melissa
    Eitel, Kelsey
    Moore, Daniel J.
    Powers, Alvin C.
    [J]. PLOS ONE, 2016, 11 (07):
  • [10] Does the Use of a Diabetes Electronic Medical Record Template Lead to Improvement of Screening for Complications of Type 1 Diabetes Mellitus in the Pediatric Population?
    Choudhary, Deepak
    Cleveland, Deborah A.
    Agdere, Levon
    Graetz, Riley
    Etienne, David
    [J]. PEDIATRICS, 2018, 141